TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
EMBC

Embecta Corp

Healthcare · Medical Instruments & Supplies

5.70$ -2.4% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Cash Flow

Embecta Corp (EMBC) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at 42 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow EMBC
Line item Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
121 120 130 85 139 183 33 58 60 -13 -9.3 30 -13 24 -2.1 27 -5.3 32 81 84 17 31 42 174
9.3 10 9.9 8.6 8.4 6.7 9.1 7.5 7.2 8.0 8.1 9.3 9.2 10 11 5.7 12 6.5 12 5.3 10 13 8.0 36
3.8 2.9 2.9 3.4 4.6 3.9 5.8 4.4 5.5 5.8 5.3 4.9 7.3 6.5 6.3 6.2 8.9 7.3 5.9 9.5 5.9 5.7 9.9 31
16 5.6 8.8 – 6.8 5.7 16 33 6.9 5.6 6.3 – – – – – – – – – – – – –
-1.4 1.8 6.3 -25 25 91 -57 26 8.3 -44 -42 -3.1 -34 -0.3 -33 19 -41 -16 9.1 24 -41 7.9 -2.3 -11
11 5.2 7.7 13 4.3 5.8 5.3 8.6 4.7 5.8 6.8 9.2 2.7 3.4 9.7 0.0 1.5 0.1 0.4 7.3 0.6 0.5 1.1 9.5
-12 -6.3 -7.7 -13 -4.3 -5.8 -5.3 -8.6 -4.7 -5.8 -6.8 -9.2 -2.7 -3.4 -9.7 – -1.5 -0.1 -0.4 -7.3 9.5 -0.5 -130 -128
– – – – – – – 8.6 8.6 17 8.6 8.6 8.6 8.6 8.6 8.7 8.8 8.7 8.7 8.8 8.9 8.9 0.6 27
– – – – – – – – -2.8 -0.2 -0.4 -0.2 -2.2 -0.5 -0.1 -0.2 -3.7 -0.9 -1.1 5.7 -4.8 – -8.7 –
1,450 1,450 1,450 – 1,450 1,450 -3.3 -3.3 -2.4 -2.4 -2.3 – – – – -28 -33 -28 -53 -73 -38 -38 127 -22
-110 -113 -122 -72 -135 90 3.3 -7.1 -6.1 -21 -12 -9.7 -14 -12 -12 -37 -45 -37 -63 -82 -52 -42 112 -62
264 264 -122 -72 -135 264 28 39 54 -39 -29 9.1 -28 7.8 -25 -7.6 -58 -4.4 21 -5.0 -24 -11 25 -15
110 115 122 72 135 177 28 49 56 -19 -16 20 -16 21 -12 27 -6.8 32 81 77 17 31 41 165

LTM = last twelve months (sum of the four most recent quarters).

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?